Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Intensity Therapeutics (INTS) Institutional Ownership

Intensity Therapeutics logo
$4.57 -0.01 (-0.22%)
As of 12:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Intensity Therapeutics (NASDAQ:INTS)

Current
Institutional Ownership
Percentage
3.74%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$10.44M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$3.28M
Get INTS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intensity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

INTS Institutional Buying and Selling by Quarter

Intensity Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/9/2026 Corient Private Wealth LLC100,000$41K0.0%N/A3.968%
2/19/2026 Corient Private Wealth LLC100,000$41K0.0%N/A0.158%
2/13/2026 State Street Corp136,200$56K0.0%+839.3%0.227%
2/12/2026 Jane Street Group LLC62,755$26K0.0%N/A0.104%
2/9/2026 Geode Capital Management LLC460,248$189K0.0%+77.8%0.766%
2/5/2026 Sapient Capital LLC650,151$244K0.0%-33.4%1.083%
2/5/2026 Mesirow Financial Investment Management Inc.251,000$103K0.0%+25.5%0.418%
1/27/2026 Legacy Advisors LLC153,447$63K0.0%N/A0.255%
11/12/2025 Mesirow Financial Investment Management Inc.200,000$49K0.0%+81.8%0.333%
8/14/2025 Sentinus LLC199,316$61K0.0%+630.0%0.795%
8/4/2025 Mesirow Financial Investment Management Inc.110,000$34K0.0%+175.0%0.439%
5/15/2025Armistice Capital LLC872,547$1.72M0.0%-22.6%5.778%
5/8/2025Mesirow Financial Investment Management Inc.40,000$79K0.0%+100.0%0.265%
4/15/2025Sapient Capital LLC976,797$1.92M0.0%+3.6%6.469%
2/18/2025GTS Securities LLC19,030$34K0.0%-49.0%0.126%
2/17/2025Citadel Advisors LLC14,964$26K0.0%N/A0.099%
2/7/2025Mesirow Financial Investment Management Inc.20,000$35K0.0%-54.7%0.132%
2/3/2025Sigma Planning Corp54,837$97K0.0%+14.9%0.363%
1/29/2025Sapient Capital LLC942,841$1.66M0.0%-6.7%6.244%
11/16/2024Geode Capital Management LLC64,349$246K0.0%+35.1%0.467%
8/12/2024Blair William & Co. IL37,805$185K0.0%N/A0.276%
4/26/2024Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322%
4/23/2024Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382%
2/9/2024Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327%
2/6/2024Sapient Capital LLC200,000$1.71M0.0%N/A1.459%
2/1/2024Sigma Planning Corp34,443$295K0.0%-28.5%0.251%
1/29/2024Sapient Capital LLC200,000$1.71M0.1%N/A1.459%
11/21/2023Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360%
11/6/2023Sigma Planning Corp48,144$191K0.0%N/A0.352%


INTS Institutional Ownership - Frequently Asked Questions

During the previous two years, 13 institutional investors and hedge funds held shares of Intensity Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($1.72M), Sapient Capital LLC ($244K), Geode Capital Management LLC ($189K), Blair William & Co. IL ($185K), Mesirow Financial Investment Management Inc. ($103K), Sigma Planning Corp ($97K), and Legacy Advisors LLC ($63K).Learn more on Intensity Therapeutics' institutional investors.

3.74% of Intensity Therapeutics' stock is owned by institutional investors. Learn more on INTS's institutional investor holdings.

Of the 11 institutional investors that purchased Intensity Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Mesirow Financial Investment Management Inc. ($231K), Geode Capital Management LLC ($218.09K), Corient Private Wealth LLC ($200K), Sentinus LLC ($172.01K), Legacy Advisors LLC ($153.45K), State Street Corp ($121.70K), and Jane Street Group LLC ($62.76K).

Institutional investors have bought a total of 1,122,271 shares in the last 24 months. This purchase volume represents approximately $10.44M in transactions.

The following institutional investors have sold Intensity Therapeutics stock in the last 24 months: Sapient Capital LLC ($326.65K).

Institutional investors have sold a total of 326,646 shares in the last 24 months. This volume of shares sold represents approximately $3.28M in transactions.



This page (NASDAQ:INTS) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners